---
schema_version: "secwatch.filing_event.v1"
accession: "0001093557-23-000022"
form_type: "8-K"
ticker: "DXCM"
cik: "0001093557"
company_name: "DEXCOM INC"
filed_at: "2023-02-09T23:59:59+00:00"
generated_at: "2026-06-19T19:13:22.571974+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.85
calibrated_materiality_score: 0.85
confidence: "high"
source: SEC EDGAR
---

# Dexcom Q4 revenue $815.2M (+17% YoY); G7 CGM FDA cleared; guides 2023 rev $3.35-3.49B

## Summary
- Q4 2022 revenue $815.2M (+17% reported, +20% organic); U.S. +17%, international +15% (organic +27%).
- GAAP operating income $125.4M (15.4% margin) vs $0.6M in Q4 2021; non-GAAP operating income $172.1M (21.1% margin).
- GAAP EPS $0.22 diluted; non-GAAP EPS $0.34 diluted; cash & marketable securities $2.46B.
- FDA cleared Dexcom G7 CGM for ages 2+; rollout in U.S. market in 2023.
- FY2023 guidance: revenue $3.35-3.49B (15-20% growth); non-GAAP gross margin 62-63%; non-GAAP op margin ~16.5%; Adj. EBITDA margin ~26%.

## SEC filing metadata
- accession: 0001093557-23-000022
- form_type: 8-K
- ticker: DXCM
- cik: 0001093557
- company_name: DEXCOM INC
- filed_at: 2023-02-09T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.85
- calibrated_materiality_score: 0.85
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1093557/000109355723000022/0001093557-23-000022-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1093557/000109355723000022/dxcm-20230209.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001093557-23-000022
- JSON: https://secwatch.observer/filing/0001093557-23-000022.json
- Plain text: https://secwatch.observer/filing/0001093557-23-000022.txt

## Key facts
- Earnings Releases
  DEXCOM INC updated its quarter and year ended December 31, 2022 guidance (reaffirmed).
  - Period: quarter and year ended December 31, 2022
  - Guidance: reaffirmed
  - Result: reported results
  source text: issued a press release announcing its financial results for the quarter and year ended December 31, 2022
  evidence_url: https://www.sec.gov/Archives/edgar/data/1093557/000109355723000022/0001093557-23-000022-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.